National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Hepatocyte nuclear factor 1ß (HNF1ß)–associated disease



Other Names:
Hepatocyte nuclear factor 1 beta–associated disease; Renal cysts and diabetes

Hepatocyte nuclear factor 1 Beta-associated diseases (HNF1B-associated diseases) are a group of genetic conditions that affect the kidney as well as other organ systems.[1][2] The most common symptoms are associated with kidney abnormalities. Other signs and symptoms may include diabetes at a young age, genital abnormalities, and problems with pancreas and liver function. Not everyone who has an HNF1B-associated disease will have the same signs and symptoms. HNF1B-associated disease is caused by a mistake (mutation) in the HNF1B gene. This is one of the genes responsible for regulating early development of many of the body’s organs. Mutations in HNF1B are inherited in families in an autosomal dominant pattern. HNF1B-associated disease is diagnosed based on the symptoms, family history and genetic testing. Treatment for this condition is based on the symptoms. Kidney disease and kidney failure may be treated with dialysis and kidney transplant. The long-term outlook for people with HNF1B-associated disease depends on the severity of symptoms.[1][2]   
Last updated: 2/20/2019

The signs and symptoms of HNFB1-associated disease can vary from person to person. Kidney abnormalities associated with HNF1B-associated disease can occur at any age, from infancy to adulthood.[1][5] The kidney abnormalities seen with HNFB1-associated disease can include:

Small, fluid-filled sacs in the kidney (renal cysts
Small, abnormally shaped kidney
An absent kidney
Abnormalities of internal kidney structure
Kidney failure (end-stage renal disease)

Additional signs and symptoms can include [2]:
Diabetes before age 25 (but can occur at any age)
Underdeveloped pancreas and abnormal pancreatic function
High levels of liver enzymes suggesting abnormal liver function 
Abnormalities of the male and female sex organs  (genitals)
Over-active parathyroid gland causing too much calcium in the body
Low magnesium levels that can cause muscle weakness and spasms
Gout at a young age
Possible increased risk for kidney cancer

The HNF1B  gene is one of many genes found on chromosome 17. In conditions that involve missing pieces of chromosome 17, the HNF1B gene might be missing along with other genes, resulting in a loss of the HNF1B protein and other proteins. Missing pieces of chromosome 17 that involve the HNF1B gene, along with other missing genes, have been associated with epilepsy, autism spectrum disorder and developmental delay.[2][3]

Last updated: 2/20/2019

HNF1B-associated disease is caused by a mistake (mutation) in the HNF1B gene, which is responsible for making a protein that is involved in the early development of many different organs within the body.[1] Mutations in the HNF1B gene can cause abnormal development of the kidneys, pancreas, parathyroid gland and liver.[4]
Last updated: 2/20/2019

HNF1B-associated disease can be inherited in an autosomal dominant pattern.[1][2] All individuals inherit two copies of each gene. In autosomal dominant conditions, having a mutation in just one copy of the associated [HNF1B] gene causes the person to have the disease. Many people who have HNF1B-associated disease are born with this condition due to a new genetic mutation (de novo) and do not have a history of this condition in their family. There is nothing either parent can do, before or during pregnancy, to cause a child to have this.

Each child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the HNF1B mutation and HNF1B-associated disease. Children who inherit the HNF1B mutation will have HNF1B-associated disease, although they could be more or less severely affected than their parent.
Last updated: 2/20/2019

The diagnosis of HNF1B-associated disease is made based on the symptoms and genetic testing.  A family history of kidney disease, diabetes or gout at an early age may be helpful, but many people with HNF1B-associated disease are the first person in their family to have the diagnosis. Laboratory testing may include blood tests to monitor kidney function, check for diabetes, and measure magnesium and calcium.[5]
Last updated: 2/20/2019

There is no specific treatment for HNF1B-associated disease. Treatment is based on individual symptoms. Kidney disease can be managed with dialysis. Kidney transplant is an option for treating kidney failure.[5] Some people with this condition may also benefit from a pancreas transplant. Gout can be prevented with certain medications (allopurinol  or febuxostat) or managed with nonsteroidal anti-inflammatories.[5] Diabetes can be managed with medication and diet.
Last updated: 2/20/2019

The long-term outlook for people with HNF1B-associated disease varies based on the severity of the symptoms.[2] Early diagnosis may be helpful for children with this condition.[5]
Last updated: 2/20/2019

The exact prevalence of HNF1B-associated disease is difficult to estimate.[1] Renal cysts and diabetes may occur is about 1-9/1,000,000 people.[3]
Last updated: 2/20/2019

Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.

Organizations Providing General Support


Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.


  1. Verhave JC, Bech AP, Wetzels JFM, Nijenhuis T. Hepatocyte Nuclear Factor 1ß–Associated Kidney Disease: More than Renal Cysts and Diabetes. J Am Soc Nephrol. Feb 2016; 25(2):345-353. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731131.
  2. Bockenhauer D, Jaureguiberry G. HNF1B-associated clinical phenotypes: the kidney and beyond. Ped Nephr. May 2016; 31(5):707-714. https://www.ncbi.nlm.nih.gov/pubmed/26160100.
  3. Owen K. Renal Cyst and Diabetes syndrome. Orphanet. Nov 2014; https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=12168.
  4. Van der Made CI, Hoorn HJ, de la Faille R, Karaasian H, Knower NV, Hoenderop JG, Vargas Poussou R, de Baaij JH. Hypomagnesemia as first clinical manifestation of ADTKD-HNF1B: A case series and literature review. Am J Nephrol. 2015; 42(1):85-90. https://www.ncbi.nlm.nih.gov/pubmed/26340261.
  5. Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Kidney Disease: Improving Global Outcomes. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Kidney Int. Oct 2015; 88(4):676-683. https://www.ncbi.nlm.nih.gov/pubmed/25738250.